According to Zacks, “Xylem believes that solid sales in utilities, industrial and commercial end-markets will benefit its top-line performance in the quarters ahead. This along with pricing and productivity initiatives will continue to boost profitability. For 2019, the company anticipates adjusted earnings of $3.20-$3.40 per share, up 11-18% year over year at the mid-point. Revenues are projected to increase 2-4% year over year to $5.3-$5.4 billion, with organic sales increasing 4-6% on the back of strengthening end-markets. However, material price inflation on account of tariffs might dent bottom-line performance. Also, foreign exchange headwind also remains a cause of concern, with 5 cents per share of headwinds expected in 2018. Year to date, the company's shares have underperformed the industry and also look relatively overvalued.”
Several other research analysts have also recently commented on XYL. Boenning Scattergood reiterated a buy rating on shares of Xylem in a research note on Friday, March 22nd. Janney Montgomery Scott cut Xylem from a buy rating to a neutral rating in a research note on Friday, March 29th. Oppenheimer set a $80.00 price target on Xylem and gave the stock a buy rating in a research note on Monday, February 4th. ValuEngine cut Xylem from a buy rating to a hold rating in a research note on Monday, February 4th. Finally, BMO Capital Markets reiterated a buy rating and issued a $85.00 price target on shares of Xylem in a research note on Monday, February 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the stock. Xylem currently has an average rating of Buy and an average price target of $79.64.
NYSE:XYL opened at $82.44 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.08 and a current ratio of 1.51. Xylem has a one year low of $60.65 and a one year high of $82.70. The stock has a market capitalization of $14.81 billion, a P/E ratio of 28.63, a price-to-earnings-growth ratio of 1.42 and a beta of 1.14.
Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, January 31st. The industrial products company reported $0.88 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.88. Xylem had a return on equity of 19.89% and a net margin of 10.54%. The business had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.36 billion. As a group, equities research analysts predict that Xylem will post 3.32 earnings per share for the current year.
In other Xylem news, insider Kenneth Napolitano sold 35,526 shares of the company’s stock in a transaction that occurred on Monday, February 4th. The stock was sold at an average price of $70.17, for a total transaction of $2,492,859.42. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Tomas Brannemo sold 559 shares of the company’s stock in a transaction that occurred on Thursday, February 21st. The shares were sold at an average price of $74.44, for a total value of $41,611.96. Following the transaction, the insider now directly owns 10,568 shares of the company’s stock, valued at $786,681.92. The disclosure for this sale can be found here. Insiders have sold 80,195 shares of company stock worth $6,000,933 in the last 90 days. 0.85% of the stock is currently owned by insiders.
Several large investors have recently bought and sold shares of XYL. Norges Bank bought a new position in shares of Xylem during the fourth quarter valued at approximately $251,391,000. Impax Asset Management Group plc grew its holdings in shares of Xylem by 18.3% during the fourth quarter. Impax Asset Management Group plc now owns 4,299,123 shares of the industrial products company’s stock valued at $286,837,000 after purchasing an additional 666,437 shares during the last quarter. Amundi Pioneer Asset Management Inc. grew its holdings in shares of Xylem by 61.3% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,662,661 shares of the industrial products company’s stock valued at $110,933,000 after purchasing an additional 631,858 shares during the last quarter. Ceredex Value Advisors LLC bought a new position in shares of Xylem during the fourth quarter valued at approximately $39,742,000. Finally, Ardevora Asset Management LLP bought a new position in shares of Xylem during the fourth quarter valued at approximately $35,408,000. 86.64% of the stock is owned by institutional investors.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Featured Article: What is a good rate of return for a mutual fund?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.